Just wanted to give Flight_19's viewpoint on this.
Post# of 148166
"This concern (about protection of Leronlimab's formula and manufacturing) is moot IMO, since the manufacturing is being performed by Samsung. There has been a complete Tech Transfer to Samsung by CYDY for the 'recipe' to manufacture LL and is covered under licensing to manufacture and the Quality Agreement. I believe the manufacturing rights to manufacture LL are owned by CYDY and licensed to the manufacturing site under a manufacturing agreement."